Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Therapeutic prostate-specific antigen (PSA) –targeted poxviral vaccines for prostate cancer have been well tolerated. PROSTVAC-VF treatment was evaluated for safety and for prolongation of progression-free survival (PFS) and overall survival (OS) in a randomized, controlled, and blinded pha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kantoff, Philip W., Schuetz, Thomas J., Blumenstein, Brent A., Glode, L. Michael, Bilhartz, David L., Wyand, Michael, Manson, Kelledy, Panicali, Dennis L., Laus, Reiner, Schlom, Jeffrey, Dahut, William L., Arlen, Philip M., Gulley, James L., Godfrey, Wayne R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834462/
https://ncbi.nlm.nih.gov/pubmed/20100959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.0597
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados